{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:21:39Z","timestamp":1787242899630,"version":"build-2736575974"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T00:00:00Z","timestamp":1696982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Moyamoya disease (MMD), also known as abnormal cerebral vascular network disease, is characterized by progressive occlusion or stenosis of the internal carotid and cerebral arteries, as well as the formation of an abnormal cerebral vascular network. It can occur anywhere in the world but is most common in China, Japan, and the Republic of Korea. In recent years, there have been increasing reports on the coexistence of thyroid diseases and MMD, but the mechanism of their coexistence is still unclear. For this article, we used keywords such as \u201cmoyamoya disease\u201d, \u201cthyroid\u201d, \u201cGrave disease\u201d, \u201cthyrotoxicosis\u201d, and \u201cthyroid autoimmune antibodies\u201d to search for 52 articles that met the requirements in medical databases such as PubMed and Web of Science. This article also reviews the research on the role of thyroid hormone, the mechanism of immune antibodies, the possible correlation between thyroid diseases and MMD disease genes, and the treatment methods, and discusses the possible relationship between MMD and thyroid diseases to provide a reference for the pathogenesis and treatment of MMD with thyroid diseases.<\/jats:p>","DOI":"10.3389\/fendo.2023.1233567","type":"journal-article","created":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T05:47:38Z","timestamp":1697003258000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Research progress on moyamoya disease combined with thyroid diseases"],"prefix":"10.3389","volume":"14","author":[{"given":"Guibo","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XueYi","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuaifeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,10,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s00381-012-1708-x","article-title":"Discovery of cerebrovascular moyamoya disease: research during the late 1950s and early 1960s","volume":"28","author":"Oshima","year":"2012","journal-title":"Childs Nerv Syst"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70240-0","article-title":"Moyamoya disease: current concepts and future perspectives","volume":"7","author":"Kuroda","year":"2008","journal-title":"Lancet Neurol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s10143-018-0994-5","article-title":"Progress in moyamoya disease","volume":"43","author":"Shang","year":"2020","journal-title":"Neurosurg Rev"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2011-301387","article-title":"Regional differences in incidence and patient characteristics of moyamoya disease: a systematic review","volume":"83","author":"Kleinloog","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2015.02.037","article-title":"Prevalence of autoimmune disease in moyamoya disease patients in Western Chinese population","volume":"351","author":"Chen","year":"2015","journal-title":"J Neurol Sci"},{"key":"B6","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.ando.2018.09.002","article-title":"Graves' disease: Introduction, epidemiology, endogenous and environmental pathogenic factors","volume":"79","author":"W\u00e9meau","year":"2018","journal-title":"Ann Endocrinol (Paris)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnaa022","article-title":"New therapeutic horizons for graves' Hyperthyroidism","volume":"41","author":"Lane","year":"2020","journal-title":"Endocr Rev"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1159\/000085736","article-title":"Determination of the levels of anti-thyroid-stimulating hormone receptor antibody with thyroid peroxidase antibody in Omani patients with Graves' disease","volume":"14","author":"Alnaqdy","year":"2005","journal-title":"Med Princ Pract"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3345\/kjp.2014.57.6.287","article-title":"Two adolescent patients with coexistent Graves' disease and Moyamoya disease in Korea","volume":"57","author":"Cheon","year":"2014","journal-title":"Korean J Pediatr"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2005.102.6.1013","article-title":"Moyamoya disease associated with Graves disease: special considerations regarding clinical significance and management","volume":"102","author":"Im","year":"2005","journal-title":"J Neurosurg"},{"key":"B11","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1111\/ene.12425","article-title":"Association of moyamoya disease with thyroid autoantibodies and thyroid function: a case-control study and meta-analysis","volume":"21","author":"Lei","year":"2014","journal-title":"Eur J Neurol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3343\/alm.2021.41.1.77","article-title":"reference intervals for thyroid-associated hormones and the prevalence of thyroid diseases in the chinese population","volume":"41","author":"Zou","year":"2021","journal-title":"Ann Lab Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.110.608471","article-title":"Increased thyroid function and elevated thyroid autoantibodies in pediatric patients with moyamoya disease: a case-control study","volume":"42","author":"Li","year":"2011","journal-title":"Stroke"},{"key":"B14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3978\/j.issn.2305-5839.2014.08.03","article-title":"Moyamoya syndrome associated with Graves' disease: a case series study","volume":"2","author":"Ni","year":"2014","journal-title":"Ann Transl Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.11.032","article-title":"Thyroid disease as a risk factor for cerebrovascular disease","volume":"24","author":"Yang","year":"2015","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2176\/nmc.52.245","article-title":"Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis)","volume":"52","author":"Hashimoto","year":"2012","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2013.02.018","article-title":"Coexistence of moyamoya and Graves' diseases: the clinical characteristics and treatment effects of 21 Chinese patients","volume":"115","author":"Li","year":"2013","journal-title":"Clin Neurol Neurosurg"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2015.30.4.543","article-title":"Fatal ischemic stroke in a case of progressive moyamoya vasculopathy associated with uncontrolled thyrotoxicosis","volume":"30","author":"Ku","year":"2015","journal-title":"Korean J Intern Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2010.03.006","article-title":"Moyamoya syndrome associated with Graves' disease: a case report and review of the literature","volume":"20","author":"Malik","year":"2011","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"B20","article-title":"Rapidly progressive fatal bihemispheric infarction secondary to Moyamoya syndrome in association with Graves thyrotoxicosis","volume":"27","author":"Hsu","year":"2006","journal-title":"AJNR Am J Neuroradiol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.45.1543","article-title":"Co-morbidity of moyamoya disease with Graves' disease. report of three cases and a review of the literature","volume":"45","author":"Sasaki","year":"2006","journal-title":"Intern Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.4158\/EP.9.4.290","article-title":"Potential association of thyrotoxicosis with vitamin B and folate deficiencies, resulting in risk for hyperhomocysteinemia and subsequent thromboembolic events","volume":"9","author":"Colleran","year":"2003","journal-title":"Endocr Pract"},{"key":"B23","article-title":"A case of Graves' diseases associated with intracranial moyamoya vessels and tubular stenosis of extracranial internal carotid arteries","volume":"93","author":"Liu","year":"1994","journal-title":"J Formos Med Assoc"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3171\/2015.4.JNS142936","article-title":"Increased prevalence of autoimmune disease in patients with unilateral compared with bilateral moyamoya disease","volume":"124","author":"Chen","year":"2016","journal-title":"J Neurosurg"},{"key":"B25","article-title":"[Autoimmune antibody in moyamoya disease]","volume":"14","author":"Wanifuchi","year":"1986","journal-title":"No Shinkei Geka"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.14027","article-title":"Association between Graves' disease and risk of incident systemic lupus erythematosus: A nationwide population-based cohort study","volume":"24","author":"Lee","year":"2021","journal-title":"Int J Rheum Dis"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1258\/000456306776865043","article-title":"Clinical and laboratory aspects of thyroid autoantibodies","volume":"43","author":"Sinclair","year":"2006","journal-title":"Ann Clin Biochem"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00521","article-title":"Thyroid autoimmunity: role of anti-thyroid antibodies in thyroid and extra-thyroidal diseases","volume":"8","author":"Fr\u00f6hlich","year":"2017","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.11.037","article-title":"Thyroid autoantibodies and the clinical presentation of moyamoya disease: A prospective study","volume":"27","author":"Lanterna","year":"2018","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.109.562264","article-title":"Association of thyroid autoantibodies with moyamoya-type cerebrovascular disease: a prospective study","volume":"41","author":"Kim","year":"2010","journal-title":"Stroke"},{"key":"B31","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s10143-011-0311-z","article-title":"Concurrent Graves' disease and intracranial arterial stenosis\/occlusion: special considerations regarding the state of thyroid function, etiology, and treatment","volume":"34","author":"Ohba","year":"2011","journal-title":"Neurosurg Rev"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/ene.12397","article-title":"Thyroid antibodies are associated with stenotic lesions in the terminal portion of the internal carotid artery","volume":"21","author":"Tanaka","year":"2014","journal-title":"Eur J Neurol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s10143-013-0511-9","article-title":"Pathophysiology and management of intracranial arterial stenosis around the circle of Willis associated with hyperthyroidism: case reports and literature review","volume":"37","author":"Matano","year":"2014","journal-title":"Neurosurg Rev"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000377","article-title":"Autoimmune thyroiditis as a risk factor for stroke: a historical cohort study","volume":"82","author":"Karch","year":"2014","journal-title":"Neurology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s12883-020-01923-w","article-title":"Intracranial arterial stenosis associated with Hashimoto's disease: angiographic features and clinical outcomes","volume":"20","author":"Hamano","year":"2020","journal-title":"BMC Neurol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2016.08.010","article-title":"Present yourself! By MHC class I and MHC class II molecules","volume":"37","author":"Rock","year":"2016","journal-title":"Trends Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3171\/2015.4.JNS142900","article-title":"Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease","volume":"124","author":"Kim","year":"2016","journal-title":"J Neurosurg"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.07.004","article-title":"Significant association of the RNF213 p.R4810K polymorphism with quasi-moyamoya disease","volume":"25","author":"Morimoto","year":"2016","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000000592","article-title":"Association of HLA-DQA2 and HLA-B with moyamoya disease in the chinese han population","volume":"7","author":"Wan","year":"2021","journal-title":"Neurol Genet"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/S0303-8467(97)00051-6","article-title":"Analysis of class II genes of human leukocyte antigen in patients with moyamoya disease","author":"Inoue","year":"1997","journal-title":"Clin Neurol Neurosurg"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/BF02767027","article-title":"DNA typing of HLA in the patients with moyamoya disease","volume":"42","author":"Inoue","year":"1997","journal-title":"Jpn J Hum Genet"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3340\/jkns.2009.46.6.558","article-title":"Association of HLA-DR and -DQ genes with familial moyamoya disease in koreans","volume":"46","author":"Hong","year":"2009","journal-title":"J Korean Neurosurg Soc"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/gene.2008.26","article-title":"Analysis of HLA class II genes in Hashimoto's thyroiditis reveals differences compared to Graves' disease","volume":"9","author":"Zeitlin","year":"2008","journal-title":"Genes Immun"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2020.12.007","article-title":"Critical amino acid variants in HLA-DRB1 allotypes in the development of Graves' disease and Hashimoto's thyroiditis in the Japanese population","volume":"82","author":"Katahira","year":"2021","journal-title":"Hum Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jaut.2015.07.009","article-title":"Immunogenetics of autoimmune thyroid diseases: A comprehensive review","volume":"64","author":"Lee","year":"2015","journal-title":"J Autoimmun"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0220858","article-title":"Identification of HLA-DRB1*04:10 allele as risk allele for Japanese moyamoya disease and its association with autoimmune thyroid disease: A case-control study","volume":"14","author":"Tashiro","year":"2019","journal-title":"PloS One"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.2176\/nmc.50.668","article-title":"Familial moyamoya disease associated with Graves' disease in a mother and daughter","volume":"50","author":"Tokimura","year":"2010","journal-title":"Two Case Rep Neurol Med Chir (Tokyo)"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1159\/000502571","article-title":"Fluctuations in moyamoya vasculopathy associated with basedow disease depending on thyroid hormone status","volume":"12","author":"Hidaka","year":"2020","journal-title":"Case Rep Neurol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-16-0045","article-title":"Fatal outcome in a Hispanic woman with moyamoya syndrome and Graves' disease","volume":"2016","author":"Choi","year":"2016","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.2176\/nmc.50.977","article-title":"Efficacy of revascularization surgery for moyamoya syndrome associated with Graves' disease","volume":"50","author":"Endo","year":"2010","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"B51","doi-asserted-by":"publisher","first-page":"105414","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105414","article-title":"Moyamoya disease associated with graves' Disease and down syndrome: A case report and literature review","volume":"30","author":"Nakamura","year":"2021","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s00701-015-2422-8","article-title":"Moyamoya disease concurrent with Graves' disease treated by direct bypass: clinical features and treatment strategies","volume":"157","author":"Ryu","year":"2015","journal-title":"Acta Neurochir (Wien)"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1233567\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T05:47:45Z","timestamp":1697003265000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1233567\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,11]]},"references-count":52,"alternative-id":["10.3389\/fendo.2023.1233567"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1233567","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,11]]},"article-number":"1233567"}}